Atlas Trials

High Risk Proliferative Diabetic Retinopathy

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High Risk Proliferative Diabetic Retinopathy

RecordFirmDate
Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy. (NCT01941329)Association for Innovation and Biomedical Research on Light and Image2014-04-01
Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy (NCT01280929)José Cunha-Vaz2010-09-01
Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR. (NCT01281098)Association for Innovation and Biomedical Research on Light and Image2010-03-01

Track High Risk Proliferative Diabetic Retinopathy automatically

Every clearance here is in the API, with alerts when new ones post.